Back to results
US 10,293,005 B2Granted
Use of gram negative species to treat atopic dermatitis
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIan Antheni Myles, Sandip K. Datta
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Claims10
A pharmaceutical composition for treating atopic dermatitis comprising:
- a therapeutically effective amount of at least one strain of Roseomonas mucosa, wherein said strain of Roseomonas mucosa comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, and SEQ ID NO:
- 3, and wherein said at least one strain of Roseomonas mucosa is isolated from a subject that does not have atopic dermatitis;
- and
- a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is in a topical dosage form selected from the group consisting of a cream, gel, foam, ointment, and lotion.
3 more elements
Dependencies are inferred from the claim text.